bottles of Monsantos Roundup glyphosate herbicide on a store shelf

Bayer Notches More Wins in Roundup Weedkiller Cancer Trials

March 5, 2024 | Source: Reuters | by Brendan Pierson

March 5 (Reuters) – Bayer (BAYGn.DE), opens new tab on Tuesday said it won a trial in a lawsuit brought by a retired postal service worker in Pennsylvania who alleged he developed non-Hodgkins lymphoma from using the company’s Roundup weedkiller.

In addition to the jury verdict in the Philadelphia Court of Common Pleas, Bayer said a California farmer, who said he contracted the same type of cancer from exposure to the product, and his wife on Tuesday voluntarily dropped their lawsuit while a trial was underway in the in state court in Sonoma County, California.

“We continue to stand behind the safety of Roundup and will confidently defend the safety of our products and our good faith actions in any future litigation,” Bayer said in a statement.
Scott Love, a lawyer for Carl Kline, the plaintiff in the Pennsylvania case, said the jury had not been allowed to hear key evidence, including a finding by a World Health Organization body that glyphosate, Roundup’s active ingredient, was likely capable of causing cancer.